Our research programme aims to help advance future clinical practice with preventive therapies for the treatment of patients with overlapping cardiovascular renal and metabolic diseases and their associated risk factors. Find out more httpbit.ly2

Our research programme aims to help advance future clinical practice with preventive therapies for the treatment of patients with overlapping #cardiovascular, renal, and metabolic diseases and their associated risk factors. Find out more: http://bit.ly/2

17:33 EDT 16 Mar 2019 | AztraZeneca

Our research programme aims to help advance future clinical practice with preventive therapies for the treatment of patients with overlapping #cardiovascular, renal, and metabolic diseases and their associated risk factors. Find out more: http://bit.ly/2TyqAVK #ACC19 pic.twitter.com/UpOZaHw68u